CATALOGO DEI PRODOTTI DELLA RICERCA

Sacerdoti, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.339
EU - Europa 3.260
AS - Asia 1.592
OC - Oceania 18
SA - Sud America 12
AF - Africa 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.323
CN - Cina 1.064
GB - Regno Unito 862
FR - Francia 549
IE - Irlanda 522
RU - Federazione Russa 471
SG - Singapore 343
UA - Ucraina 263
SE - Svezia 228
IT - Italia 157
DE - Germania 102
VN - Vietnam 94
FI - Finlandia 57
HK - Hong Kong 44
AU - Australia 18
CA - Canada 16
BE - Belgio 11
TR - Turchia 10
NL - Olanda 7
IN - India 6
BR - Brasile 5
KR - Corea 5
JP - Giappone 4
NO - Norvegia 4
AT - Austria 3
HU - Ungheria 3
ID - Indonesia 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
AR - Argentina 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
IR - Iran 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.226
Salva come PNG Salva come JPEG
Città #
Southend 844
Jacksonville 788
Chandler 548
Dublin 520
Ashburn 317
Lawrence 262
Princeton 262
Wilmington 220
Singapore 213
Beijing 182
Jinan 120
Ann Arbor 80
Dong Ket 79
Shenyang 78
Sindelfingen 59
Helsinki 52
Nanjing 52
Ningbo 51
Tianjin 45
Changsha 43
Haikou 41
Hebei 41
Hong Kong 38
Seattle 33
Zhengzhou 33
Taizhou 32
Hangzhou 31
Fairfield 30
Nanchang 30
Verona 30
Houston 26
Milan 26
Norwalk 24
Taiyuan 24
Redwood City 23
Guangzhou 22
New York 22
San Francisco 21
Lanzhou 20
Washington 20
Redmond 15
Jiaxing 14
San Diego 14
Woodbridge 13
Fuzhou 12
Brussels 11
Rome 10
Boardman 9
Bonndorf 9
Legnago 9
Toronto 9
Des Moines 8
Melbourne 8
Canberra 6
Chicago 6
Dallas 6
Los Angeles 6
Brescia 5
Seoul 5
Clearwater 4
Kemerovo 4
Lappeenranta 4
Riva 4
Santa Clara 4
São Paulo 4
Xi'an 4
Amsterdam 3
Central 3
Falls Church 3
Forest City 3
Kent 3
Lima 3
London 3
Montesilvano Marina 3
Saint Petersburg 3
Stockholm 3
Tokyo 3
Trento 3
Vienna 3
Vittuone 3
Yicheng 3
Alessandria 2
Bologna 2
Changle 2
Chaoyang 2
Frankfurt am Main 2
Genova 2
Montréal 2
Moscow 2
Niscemi 2
Nomi 2
Nuremberg 2
Oslo 2
Ponte San Pietro 2
Sesto Calende 2
Sydney 2
Zanjan 2
Absecon 1
Almere Stad 1
Amman 1
Totale 5.665
Salva come PNG Salva come JPEG
Nome #
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 98
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 96
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 86
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 83
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 76
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 61
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 59
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 57
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 56
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 55
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 54
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 53
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 53
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 53
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 52
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 51
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 51
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 50
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 50
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 48
Vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler. 47
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 47
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 47
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 47
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 46
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 46
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 46
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 45
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 45
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 45
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 45
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 45
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 45
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 44
Renal function in congestive heart failure. 44
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 44
Drugs in the prevention of rebleeding in cirrhosis 43
La profilassi primaria dell'emorragia da rottura di varici esofagee 43
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 43
Agreement and predictive validity of neurophysiological, psychometric, and psychophysical indices of hepatic encephalopathy 43
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 42
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 42
L'ipertensione portale 42
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 42
A MULTICENTER CONTROLLED-STUDY COMPARING BETA-BLOCKERS AND BETA-BLOCKERS PLUS NITRODERIVATIVES IN THE PRIMARY PROPHYLAXIS OF 1ST VARICEAL BLEEDING IN CIRRHOSIS - INTERIM ANALYSIS 42
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices. 42
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 42
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 42
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 42
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 41
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 41
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 40
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 40
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) 40
L'eco-Doppler dei vasi splancnici nella cirrosi 40
Effetto protettivo del corm-3 nei confronti del danno da ischemia-riperfusione in un modello sperimentale porcino 40
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 40
Alteration in endothelial function in cirrhosis 40
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 40
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 40
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 40
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 40
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 39
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) ON NON-OBESE DIABETES: PREVALENCE AND RELATIONSHIP WITH DOPPLER HEMODINAMIC ALTERATIONS, LEPTIN, INFLAMMATION AND OXIDATIVE STRESS 39
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 39
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 38
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 38
Role of HO/CO in the Control of Peripheral Circulation in Humans 38
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 38
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 38
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells 38
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 37
Effetti dell'Iloprost sull'emodinamica renale, sul metabolismo intrarenale del sodio e sul sistema renina-angiotensina-aldosterone. 37
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 37
Alterazioni epatiche in corso di scompenso cardiaco 37
Renal effects of nadolol in patients with liver cirrhosis 36
Impaired sodium and water excretion in preascitic cirrhosis: renal mechanisms. 36
Left ventricular diastolic function in liver cirrhosis 36
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 36
Il paradigma di Stenberg in pazienti cirrotici senza encefalopatia epatica clinicamente manifesta 35
Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis 35
Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells 35
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 35
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 35
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 35
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 35
PGE2 renali e metabolismo del sodio e dell'acqua nella cirrosi epatica anascitica 34
Clinical significance of data obtained from hepatic vein catheterization in the prognostic evaluation of patients with cirrhosis with esophageal varices. 34
Prevenzione della recidiva emorragica da rottura di varici esofagee nel cirrotico 34
Prevenzione della recidiva emorragica da rottura di varici esofagee nel cirrotico. 34
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 34
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 34
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment 34
Differences between acute and chronic effects of nadolol on portal hypertension in patients with cirrhosis: a pathophysiological interpretation 34
Splanchnic hemodynamics in portal hypertension 33
Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats 33
Imaging e valutazione emodinamica nella diagnostica epatologica 33
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins 33
Renal effects of nadolol in cirrhosis 33
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 33
Totale 4.394
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.745
article - articoli 34.959
book - libri 486
conference - conferenze 7.922
curatela - curatele 0
other - altro 260
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.118
Totale 91.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020737 0 0 3 2 6 6 3 259 16 46 63 333
2020/20211.874 251 178 60 344 264 295 23 9 12 8 332 98
2021/20221.598 104 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/2025624 298 280 46 0 0 0 0 0 0 0 0 0
Totale 8.566